Clinical Trials Logo

Cardiovascular Disorder clinical trials

View clinical trials related to Cardiovascular Disorder.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06029517 Recruiting - Clinical trials for Coronary Artery Disease

A Sugar-Sweetened Beverage Reduction Intervention for Native American Men

Start date: July 20, 2022
Phase: N/A
Study type: Interventional

This clinical trial develops and tests a culturally-appropriate educational program (Indigenous SIPin) for reducing sugar-sweetened beverage consumption in men affiliated with Native American athletics communities. Sugary drinks are drinks like pop, soda, and juice. Increased sugar consumption may lead to an increased risk of chronic diseases, including obesity, diabetes, some types of obesity-related cancers, coronary heart disease, hypertension, and dental decay. A culturally sensitive program may help reduce sugar-sweetened beverage consumption in Native American men

NCT ID: NCT05705531 Recruiting - Hodgkin Lymphoma Clinical Trials

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Start date: August 18, 2023
Phase:
Study type: Observational

This study assesses how blood cell growth patterns (clonal hematopoiesis), relates to heart health or cardiovascular disease (CVD) after treatment in patients with Hodgkin lymphoma. In some patients, cancer treatment at a young age may lead to later complications, including problems with heart health. Checking for blood cell growth patterns called therapy-related clonal hematopoiesis (t-CH) can help predict who might be at risk for heart health problems after Hodgkin lymphoma treatment. If doctors know who may be at greater risk for developing later heart complications, then they can more closely monitor those patients to prevent or detect heart complications early.